Cormorant Asset Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-9,500
| Closed | -$2.43M | – | 104 |
|
|
2021
Q2 | $2.43M | Sell |
9,500
-3,833
| -29% | -$980K | 0.08% | 88 |
|
|
2021
Q1 | $3.54M | Hold |
13,333
| – | – | 0.08% | 97 |
|
|
2020
Q4 | $4.92M | Sell |
13,333
-1,651
| -11% | -$609K | 0.12% | 79 |
|
|
2020
Q3 | $3.66M | Sell |
14,984
-8,349
| -36% | -$2.04M | 0.14% | 75 |
|
|
2020
Q2 | $6.72M | Sell |
23,333
-3,838
| -14% | -$1.11M | 0.26% | 63 |
|
|
2020
Q1 | $5.54M | Sell |
27,171
-609
| -2% | -$124K | 0.26% | 52 |
|
|
2019
Q4 | $12.4M | Sell |
27,780
-5,483
| -16% | -$2.45M | 0.5% | 44 |
|
|
2019
Q3 | $10.2M | Sell |
33,263
-5,070
| -13% | -$1.56M | 0.62% | 39 |
|
|
2019
Q2 | $12.2M | Buy |
+38,333
| New | +$12.2M | 0.7% | 37 |
|